Providing market intelligence for more than 35 years

In The News

The Apple Watch Is Scaling Back Its Health Features

The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.

"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.

'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'" 

From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.

Previously In The News

Diginets Come Of Age

The share of U.S. households that acquire their TV signals via over-the-air antenna increased to 20 percent—or about 24 million homes—from 16 percent from early 2015 through the end of 2017, according...

Fitbit Buys Smartwatch Pioneer Pebble Amid Wearables Shakeup

The smartwatch market has also slumped. Apple Watch sales are down this year, and Lenovo’s Motorola brand has dropped out of the market. Most people simply aren’t finding reasons to buy them: Smartwat...

The Simple Reason Why I Won't Buy Roku Inc.

Roku (NASDAQ:ROKU) went public on Sep. 28, its stock surging nearly 70% from its IPO price of $14 per share. The stock hit almost $30 the following day, but subsequently pulled back to the low $20s....

Roku Plunges: 3 Reasons to Buy, 4 Reasons to Sell

Last August, Parks Associates reported that Roku controlled 37% of the streaming device market in the U.S., while Amazon, Google, and Apple held shares of 24%, 18%, and 15%, respectively. All three of...